PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Recipharm recognised in the CMO Leadership Awards 2018

Recipharm has been recognised in the CMO Leadership Awards for 2018. The awards, which recognise service excellence across pharmaceutical contract manufacturers, are...
Continue Reading →
News

Source BioScience invest in digital pathology platform to enhance the outsourced histopathology service solution provided to the NHS and private healthcare.

Driving down turnaround times (TATs), to enable a more rapid diagnosis and treatment of patients is the key philosophy of Source BioScience. As a leading provider of...
Continue Reading →
News

GlaxoSmithKline scores retail deal with CVS, spreading Shingrix to thousands of pharmacies

GlaxoSmithKline has a lot riding on Shingrix, its new shingles vaccine. It's one of the key products CEO Emma Walmsley cited as growth drivers for the languishing c...
Continue Reading →
News

Novo Nordisk's semaglutide spurs major weight loss in phase 2 obesity study

  Novo Nordisk’s closely watched semaglutide has already shown it can spur weight loss in diabetic patients. Now it’s added evidence that it ...
Continue Reading →
News

Napp secures distribution rights to Celltrion’s Herzuma

Napp Pharmaceuticals has secured itself exclusive UK distribution rights to Celltrion Healthcare’s Herceptin biosimilar Herzuma. Herzuma (trastuzumab) was approv...
Continue Reading →
News

Lundbeck snaps up Parkinson’s candidate via Prexton buy

Lundbeck has announced plans to buy Prexton Therapeutics in a deal valued at up to 905 million euros. The move gives the Danish drugmaker access to Prexton’s fo...
Continue Reading →
News

TissueGene changes name to Kolon TissueGene, Inc.

By adding the name "Kolon," the new corporate identity recognizes the patient but committed support and effort by its parent company and major shareholder, the Kolon...
Continue Reading →
News

Loncar introduces China BioPharma Index

LCHINA is the first and only stock market index available to the public that follows China’s biopharma industry from both its regional and U.S. listed perspective. ...
Continue Reading →
News

MD Tokens to trade on Knovatech OTC platform in Hong Kong

With the encouraging response from the early investors in Singapore and Hong Kong, MD Tokens is expanding its community of users across Asia The mission of ...
Continue Reading →
News

Mayne pharma launches generic version of Monodox in Australia

The drug is indicated for the treatment of a number of infections, including adjunctive therapy in severe acne Australia's Mayne Pharma Group recently annou...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026